Back
Invesco S&P MidCap 400® Pure Value ETF Vs. PTC Therapeutics Industry Stock Comparison
Buy
66
RFV
Invesco S&P MidCap 400® Pure Value ETF
Last Price:
117.74
Seasonality Move:
2.82%
Sell
40
PTCT
PTC Therapeutics
Last Price:
37.52
Seasonality Move:
3.92%
Buy
66
Invesco S&P MidCap 400® Pure Value ETF (RFV)
is a Buy
Is Invesco S&P MidCap 400® Pure Value ETF a Buy, Sell or Hold?
- The current Invesco S&P MidCap 400® Pure Value ETF [RFV] share price is $118.29. The Score for RFV is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- RFV is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
PTC Therapeutics (PTCT)
is a Sell
Is PTC Therapeutics a Buy, Sell or Hold?
- The current PTC Therapeutics [PTCT] share price is $37.56. The Score for PTCT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- PTCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RFV Stock Price Chart
What is Invesco S&P MidCap 400® Pure Value ETF's stock price today?
-
The Invesco S&P MidCap 400® Pure Value ETF share price today is $118.29
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RFV is experiencing slight selling pressure.
PTCT Stock Price Chart
What is PTC Therapeutics's stock price today?
-
The PTC Therapeutics share price today is $37.56
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTCT is experiencing slight selling pressure.
RFV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.01 | Buy |
Relative Strength Index (14 RSI): | 60.35 | Buy |
Chaikin Money Flow: | -703 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (112.61 - 117.91) | Buy |
Bollinger Bands (100): | (111.55 - 116.83) | Buy |
PTCT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.06 | Buy |
Relative Strength Index (14 RSI): | 69.28 | Buy |
Chaikin Money Flow: | -221691 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.67 - 36.49) | Buy |
Bollinger Bands (100): | (31.89 - 36.41) | Buy |
RFV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 117.44 | Buy |
20-day SMA: | 114.84 | Buy |
50-day SMA: | 114.7 | Buy |
200-day SMA: | 113.65 | Buy |
8-day EMA: | 117.04 | Buy |
20-day EMA: | 115.77 | Buy |
50-day EMA: | 114.8 | Buy |
200-day EMA: | 111.94 | Buy |
PTCT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.67 | Buy |
20-day SMA: | 34.47 | Buy |
50-day SMA: | 33.72 | Buy |
200-day SMA: | 31.08 | Buy |
8-day EMA: | 36.52 | Buy |
20-day EMA: | 35.25 | Buy |
50-day EMA: | 34.22 | Buy |
200-day EMA: | 32.66 | Buy |
Invesco S&P MidCap 400® Pure Value ETF Earnings Growth & RFV Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
PTC Therapeutics Earnings Growth & PTCT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.67 per share, an increase this year of $0.38 per share, and an increase next year of $0.67 per share.
Invesco S&P MidCap 400® Pure Value ETF Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
PTC Therapeutics Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |